Research Site 27 — Tucson, Arizona

Public research footprint of Research Site 27, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Chronic Obstructive Pulmonary Disease · Primary Prevention of Atherosclerotic Cardiovascular Disease · HR Low-Positive/HER2-Negative Breast Neoplasms · Advanced Non-Small Cell Lung Cancer

Recently updated registry entries

NCT05039840 — Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus… (Active Not Recruiting)
NCT06097260 — Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for… (Terminated)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site 27?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.